Recensa Therapeutics
Recensa Therapeutics, Inc. has a new approach to treating psoriasis: targeting oxidative stress.
Business Model:
Revenue: $0
Employees: 11-50
Rankings
Industries / Tags:
Detailed Recensa Therapeutics Information
Geographic Data
Address:
City: Philadelphia
State: Pennsylvania
Zip:
Country: United States
Financial Info
Stage:
pre seed
Raised Last:
$50k
Raised Total:$77k
Social
Metrics
0Website Global Rank
0Website Monthly Traffic
Twitter Followers
Description
Recensa is developing small molecules that activate the transcription factor Nrf2, a key modulator of antioxidant response. These molecules will be embedded in topical vehicles-such as creams or lotions-and will be tested in animal models of psoriasis so we can gain FDA approval for human clinical trials. Future products may target other diseases where oxidative stress is a key factor
Contact Phone:
Contact Email:
| Announced Date | Company | Transaction | Money Raised |
|---|
| Announced Date | Transaction | Number of Investors | Money Raised | Lead Investors | 6/2016 | Pre Seed Round | 2 | $27k |
Phase 1 Ventures Phase One Ventures Phase 1 Ventures Phase One Ventures |
6/2017 | Pre Seed Round | 1 | $50k |
Phase 1 Ventures Phase 1 Ventures |
|---|
| Announced Date | Name | Price |
|---|
Employee Departments
Employee States
|
|
Revenue: 0 - 100000 Employees: Industry: Software |
Details
|
|
|
Revenue: 0 - 100000 Employees: 51 - 500 Industry: Education |
Details
|
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Blockchain |
Details
|
|
|
Revenue: 0 - 100000 Employees: 11 - 50 Industry: Industrial |
Details
|
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Advertising |
Details
|
